Trigeminal neuralgia: IncobotulinumtoxinA (Xeomin), can it decrease the pharmacological intervention? (A case series)

• मुख्य लेखकों: Meghdad Hosseini (लेखक), Farhad Asarzadegan (लेखक), Erfan Shafiee (लेखक), Shayan Alijanpour (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Babol University of Medical Sciences, 2023-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Trigeminal neuralgia is one of the most disabling facial pain syndromes. In recent years' new therapeutic strategy, incobotulinumtoxin A has emerged. The aim of the current study was to determine the time and duration of pain in 3 cases with pharmacological treatment and incobotulin...